“

Lindsey Baden added. Finally, Badenaddressed the question on the minds of many : How can drug developers speed along these clinical trials without risking safety in the end product ? There are ways to take risks in manufacturing that are financial that dont engender safety risks in the studies and those financial risks have to be thought about in the manufacturing side and the delivery side, that I would argue are appropriate risks in this setting.